Kapruvia Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

kapruvia

vifor fresenius medical care renal pharma france - difelikefalin - pruritus - visi kiti gydomieji produktai - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.

Quviviq Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

quviviq

idorsia pharmaceuticals deutschland gmbh - daridorexant hydrochloride - miego inicijavimo ir priežiūros sutrikimai - psicholeptikai - quviviq is indicated for the treatment of adult patients with insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.

Evotaz Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

evotaz

bristol-myers squibb pharma eeig - cobicistat, atazanavir - Živ infekcijos - antivirusiniai vaistai sisteminiam naudojimui - evotaz is indicated in combination with other antiretroviral medicinal products for the treatment of hiv-1 infected adults and adolescents (aged 12 years and older weighing at least 35 kg) without known mutations associated with resistance to atazanavir (see sections 4. 4 ir 5.

Incivo Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

incivo

janssen-cilag international n.v. - telapreviras - hepatitas c, lėtinis - antivirusiniai vaistai sisteminiam naudojimui - incivo, kartu su peginterferon alfa ir ribavirin, fluorouracilu ir folino genotipo-1 lėtinio hepatito c paplitimas tarp suaugusių pacientų su kompensuota kepenų liga (įskaitant kepenų cirozę):kas yra gydymo naivu;kas anksčiau buvo elgiamasi su interferonu alfa (pegylated ar ne pegylated) atskirai arba kartu su ribavirin, įskaitant relapsers, dalinis atsakas ir null gelbėtojai.

Zydelig Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

zydelig

gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.

Xtandi Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamidas - prostatos navikai - endokrininė terapija - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Xenleta Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

xenleta

nabriva therapeutics ireland dac - lefamulin acetate - pneumonia, bacterial; community-acquired infections - antibacterials sisteminio naudojimo, - xenleta is indicated for the treatment of community-acquired pneumonia (cap) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of cap or when these have failed. reikėtų atsižvelgti į oficialius nurodymus, kaip tinkamai naudoti antibakterinių veiksnių.

Enzalutamide Norameda Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

enzalutamide norameda

norameda, uab - enzalutamidas - minkštosios kapsulės - 40 mg - enzalutamide